Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Florida
| Provider | Medicare | Services |
|---|---|---|
| Zganjar, Andrew MD | $67.93 | 346 |
| Lyon, Timothy M.D. | $66.19 | 246 |
| Johnson, Derek PA-C | $60.05 | 245 |
| Tripp, Benjamin M.D. | $66.34 | 179 |
| Cobb, Charles MD | $65.28 | 148 |
| Manganiotis, Angelos M.D. | $71.53 | 132 |
| Borland, Raymond MD | $72.43 | 122 |
| Blitz, Barry MD | $69.35 | 116 |
| Popowitz, Stuart MD | $71.63 | 115 |
| Ornstein, David K MD | $70.60 | 109 |
| Liu, Alexander M.D. | $64.55 | 108 |
| King, Edward MD | $66.66 | 108 |
| Figlesthaler, William M.D. | $68.83 | 103 |
| Rao, Dinesh MD | $69.21 | 101 |
| Blau, Elliot M.D. | $72.19 | 101 |
| Biase, Joseph MD | $71.67 | 101 |
| Bergamo, Jeremy MD | $65.52 | 98 |
| Nehme, John M.D. | $71.60 | 97 |
| Fountain, Michael D.O. | $67.94 | 94 |
| Young, Paul MD | $68.37 | 93 |
| Sher, Andrew MD | $66.60 | 92 |
| Taub, Harvey MD | $68.75 | 88 |
| Scheckowitz, Edward M.D. | $71.10 | 87 |
| Carey, Robert M.D. | $63.60 | 87 |
| Harris, David M.D. | $72.31 | 86 |
Florida Pricing in Context
In Florida, CPT code 51720 (Instillation Of Anti-Cancer Drug Into Bladder) carries an average Medicare payment of $63.77 — 5% above the national benchmark of $60.79. 745 providers across the state submitted claims for this procedure in 2023, performing 15.5K total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Florida is $341.28, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Urinary Surgery procedures, the estimated commercial insurance price in Florida lands near $193.60, with self-pay cash prices typically around $155.64. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Instillation Of Anti-Cancer Drug Into Bladder cost in Florida?
The average Medicare payment for Instillation Of Anti-Cancer Drug Into Bladder in Florida is $63.77, which is 5% above the national average of $60.79. Providers in FL typically bill $341.28 for this procedure.
What does Instillation Of Anti-Cancer Drug Into Bladder cost with insurance in Florida?
With commercial insurance in Florida, Instillation Of Anti-Cancer Drug Into Bladder costs an estimated $193.60. Without insurance, the estimated cash price is $155.64. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Instillation Of Anti-Cancer Drug Into Bladder in Florida?
745 providers in Florida billed Medicare for Instillation Of Anti-Cancer Drug Into Bladder in 2023, performing 15.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Instillation Of Anti-Cancer Drug Into Bladder cheaper in Florida than the national average?
No — Instillation Of Anti-Cancer Drug Into Bladder costs 5% above the national average in Florida. The state average Medicare payment is $63.77 compared to $60.79 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.